Financial Perspectives’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64K | Hold |
52
| – | – | ﹤0.01% | 640 |
|
|
2025
Q1 | $1.7K | Hold |
52
| – | – | ﹤0.01% | 634 |
|
|
2024
Q4 | $1.88K | Hold |
52
| – | – | ﹤0.01% | 629 |
|
|
2024
Q3 | $1.62K | Hold |
52
| – | – | ﹤0.01% | 606 |
|
|
2024
Q2 | $1.39K | Hold |
52
| – | – | ﹤0.01% | 600 |
|
|
2024
Q1 | $1.77K | Hold |
52
| – | – | ﹤0.01% | 581 |
|
|
2023
Q4 | $1.51K | Hold |
52
| – | – | ﹤0.01% | 609 |
|
|
2023
Q3 | $1.43K | Hold |
52
| – | – | ﹤0.01% | 620 |
|
|
2023
Q2 | $1.56K | Hold |
52
| – | – | ﹤0.01% | 600 |
|
|
2023
Q1 | $1.88K | Hold |
52
| – | – | ﹤0.01% | 580 |
|
|
2022
Q4 | $1.86K | Hold |
52
| – | – | ﹤0.01% | 587 |
|
|
2022
Q3 | $1.76K | Hold |
52
| – | – | ﹤0.01% | 589 |
|
|
2022
Q2 | $1.5K | Hold |
52
| – | – | ﹤0.01% | 612 |
|
|
2022
Q1 | $1.68K | Hold |
52
| – | – | ﹤0.01% | 622 |
|
|
2021
Q4 | $1.52K | Hold |
52
| – | – | ﹤0.01% | 600 |
|
|
2021
Q3 | $1.39K | Hold |
52
| – | – | ﹤0.01% | 606 |
|
|
2021
Q2 | $1.6K | Sell |
52
-1,309
| -96% | -$40.3K | ﹤0.01% | 619 |
|
|
2021
Q1 | $52K | Buy |
1,361
+1,309
| +2,517% | +$50K | ﹤0.01% | 557 |
|
|
2020
Q4 | $1.31K | Hold |
52
| – | – | ﹤0.01% | 565 |
|
|
2020
Q3 | $1.08K | Hold |
52
| – | – | ﹤0.01% | 527 |
|
|
2020
Q2 | $1.24K | Hold |
52
| – | – | ﹤0.01% | 507 |
|
|
2020
Q1 | $935 | Sell |
52
-51
| -50% | -$917 | ﹤0.01% | 493 |
|
|
2019
Q4 | $2.44K | Buy |
+103
| New | +$2.44K | ﹤0.01% | 442 |
|